MedTrace Logo

Prophylaxis and Treatment of COVID-19

NCT04844541 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2025-04-24

No results posted yet for this study

Summary

An observation study evaluating physiologic responses and host biomarker expression patterns in early SARS-CoV-2 and acute respiratory infections (ARI) and among their close contacts.

Conditions

Sponsors & Collaborators

  • Joint Program Executive Office Chemical, Biological, Radiological, and Nuclear Defense Enabling Biotechnologies

    collaborator OTHER_GOV

  • Henry M. Jackson Foundation for the Advancement of Military Medicine

    lead OTHER

Principal Investigators

  • Danielle Clark, PhD · Henry M. Jackson Foundation for the Advancement of Military Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-11
Primary Completion
2024-02-21
Completion
2024-02-21

Countries

  • United States
  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04844541 on ClinicalTrials.gov